tiprankstipranks
Trending News
More News >

Dr. Reddy’s Laboratories Announces 41st AGM Notice and E-Voting Information

Story Highlights
Dr. Reddy’s Laboratories Announces 41st AGM Notice and E-Voting Information

Don’t Miss TipRanks’ Half-Year Sale

Dr Reddy’s Laboratories ( (RDY) ) has provided an announcement.

On July 2, 2025, Dr. Reddy’s Laboratories announced the publication of a newspaper advertisement regarding the notice of its 41st Annual General Meeting and e-voting information. This announcement, made in compliance with Regulation 47 of the Securities and Exchange Board of India, was published in the Business Standard and Nava Telangana newspapers. The move underscores the company’s commitment to transparency and regulatory compliance, ensuring stakeholders are informed about important corporate governance events.

The most recent analyst rating on (RDY) stock is a Buy with a $17.40 price target. To see the full list of analyst forecasts on Dr Reddy’s Laboratories stock, see the RDY Stock Forecast page.

Spark’s Take on RDY Stock

According to Spark, TipRanks’ AI Analyst, RDY is a Outperform.

Dr Reddy’s Laboratories’ strong financial performance is the most significant factor, underscored by consistent revenue growth and profitability. Technical analysis supports a favorable stock trend, although valuation is fair with modest income potential. The absence of earnings call and corporate events data did not impact the overall score.

To see Spark’s full report on RDY stock, click here.

More about Dr Reddy’s Laboratories

Dr. Reddy’s Laboratories Limited is a global pharmaceutical company based in Hyderabad, India. It is engaged in the manufacturing and marketing of a wide range of pharmaceuticals, including generic medications, active pharmaceutical ingredients (APIs), and proprietary products. The company focuses on providing affordable and innovative medicines to patients worldwide.

Average Trading Volume: 2,008,586

Technical Sentiment Signal: Strong Buy

Current Market Cap: $12.44B

Find detailed analytics on RDY stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1